Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 17, Issue 07, Pages 1083-1093
Publisher
Oxford University Press (OUP)
Online
2012-05-02
DOI
10.1017/s1461145712000399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy
- (2011) Susan M. Essock et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia
- (2011) Monica Hazra et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior
- (2011) Christoph U. Correll et al. SCHIZOPHRENIA RESEARCH
- The evolution of antipsychotic switch and polypharmacy in natural practice — A longitudinal perspective
- (2011) Chisa Tsutsumi et al. SCHIZOPHRENIA RESEARCH
- Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients
- (2010) L. Baandrup et al. ACTA PSYCHIATRICA SCANDINAVICA
- 10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia
- (2010) J. Nielsen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
- (2010) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting
- (2010) Ric M. Procyshyn et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia
- (2010) Norio Yasui-Furukori et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy
- (2010) Giovanni Santone et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics
- (2010) Chih-Ken Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy
- (2009) Joshua S. Benner et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia
- (2009) Jae Seung Chang et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia
- (2009) Lone Baandrup et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
- (2009) David C. Henderson et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Refill adherence and polypharmacy among patients with type 2 diabetes in general practice
- (2009) Rykel van Bruggen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
- (2009) Hiroyuki Uchida et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Patterns of Quetiapine Use in Psychiatric Inpatients: An Examination of Off-Label Use
- (2008) Noah S. Philip et al. Annals of Clinical Psychiatry
- Cost of antipsychotic polypharmacy in the treatment of schizophrenia
- (2008) Baojin Zhu et al. BMC Psychiatry
- High-dose and combination antipsychotic prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing
- (2008) Carol Paton et al. BRITISH JOURNAL OF PSYCHIATRY
- Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions
- (2008) Liana Urichuk et al. CURRENT DRUG METABOLISM
- Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial
- (2008) M Zink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
- (2008) C. U. Correll et al. SCHIZOPHRENIA BULLETIN
- Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study
- (2008) Diego Novick et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started